Morepen Hits Record Q2FY27 Revenue of Rs. 755 Cr; Driven by CDMO Momentum, EBITDA Surges 273% to Rs. 132 Cr in Q2FY27 and Rs. 220 Cr. in H1FY27
Oct 27, 2026
Gurugram (Haryana) [India], October 27: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) today announced its financial results for the quarter and half year ended...